| ALL | Acute lymphoblastic leukemia |
| AML | Acute myeloid leukemia |
| B-ALL | B-lineage acute lymphoblastic leukemia |
| CAR-T | Chimeric antigen receptors (chimeric T-cell receptors) |
| CNS | Central nervous system |
| DfN | Difference from normal |
| dPCR | Digital PCR |
| EFS | Event-free survival |
| FC | Flow cytometry |
| FISH | Fluorescence in situ hybridization |
| HSCT | Hematopoietic stem cell transplantation |
| I-BFM-SG | International Berlin–Frankfurt–Münster Study Group |
| IgH | Immunoglobulin H |
| LAIPs | Leukemia-associated immunophenotypes |
| MFC | Multicolor flow cytometry |
| MRD | Minimal residual disease |
| MRD-HR | Minimal residual disease—high risk |
| MRD-IR | Minimal residual disease—intermediate risk |
| MRD-SR | Minimal residual disease—standard risk |
| NGS | Next-generation sequencing |
| OS | Overall survival |
| PAS | Periodic acid Schiff |
| PCR | Polymerase chain reaction |
| qPCR | Quantitative PCR |
| RFS | Relapse-free survival |
| T-ALL | T-lineage acute lymphoblastic leukemia |
| TCR | T-cell receptor |